FI944123A0 - Farmaceutiska inhalationssammansättningar - Google Patents

Farmaceutiska inhalationssammansättningar

Info

Publication number
FI944123A0
FI944123A0 FI944123A FI944123A FI944123A0 FI 944123 A0 FI944123 A0 FI 944123A0 FI 944123 A FI944123 A FI 944123A FI 944123 A FI944123 A FI 944123A FI 944123 A0 FI944123 A0 FI 944123A0
Authority
FI
Finland
Prior art keywords
pct
composition
sec
medicament
range
Prior art date
Application number
FI944123A
Other languages
English (en)
Finnish (fi)
Other versions
FI110162B (sv
FI944123A (sv
Inventor
Lewis James Baskeyfield
Graham Frederick Jay
Paul Wright
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929205183A external-priority patent/GB9205183D0/en
Priority claimed from GB929205738A external-priority patent/GB9205738D0/en
Priority claimed from GB929205739A external-priority patent/GB9205739D0/en
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of FI944123A publication Critical patent/FI944123A/sv
Publication of FI944123A0 publication Critical patent/FI944123A0/sv
Application granted granted Critical
Publication of FI110162B publication Critical patent/FI110162B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
FI944123A 1992-03-10 1994-09-08 Förfarande för framställning av farmaceutiska inhalationssammansättningar FI110162B (sv)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB929205183A GB9205183D0 (en) 1992-03-10 1992-03-10 Formulation
GB9205183 1992-03-10
GB929205738A GB9205738D0 (en) 1992-03-17 1992-03-17 Formulations
GB9205738 1992-03-17
GB9205739 1992-03-17
GB929205739A GB9205739D0 (en) 1992-03-17 1992-03-17 Formulations
GB9300503 1993-03-10
PCT/GB1993/000503 WO1993017663A1 (en) 1992-03-10 1993-03-10 Pharmaceutical inhalation compositions

Publications (3)

Publication Number Publication Date
FI944123A FI944123A (sv) 1994-09-08
FI944123A0 true FI944123A0 (sv) 1994-09-08
FI110162B FI110162B (sv) 2002-12-13

Family

ID=27266086

Family Applications (1)

Application Number Title Priority Date Filing Date
FI944123A FI110162B (sv) 1992-03-10 1994-09-08 Förfarande för framställning av farmaceutiska inhalationssammansättningar

Country Status (12)

Country Link
US (1) US5607662A (sv)
EP (1) EP0630230B1 (sv)
JP (1) JP2736168B2 (sv)
AT (1) ATE145819T1 (sv)
CA (1) CA2131285C (sv)
DE (1) DE69306379T2 (sv)
DK (1) DK0630230T3 (sv)
ES (1) ES2099428T3 (sv)
FI (1) FI110162B (sv)
GR (1) GR3022527T3 (sv)
NO (1) NO307203B1 (sv)
WO (1) WO1993017663A1 (sv)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
US6413496B1 (en) 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
US6192882B1 (en) * 1997-02-24 2001-02-27 Aradigm Corporation Formulation and devices for monitoring the efficacy of the delivery of aerosols
US6349719B2 (en) 1997-02-24 2002-02-26 Aradigm Corporation Formulation and devices for monitoring the efficacy of the delivery of aerosols
US5891419A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
US6129905A (en) * 1997-04-21 2000-10-10 Aeropharm Technology, Inc. Aerosol formulations containing a sugar as a dispersant
US5891420A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe triancinolone acetonide aerosol formulations for oral inhalation
US6197280B1 (en) 1997-09-09 2001-03-06 Bioglan Laboratories Limited Pharmaceutical compositions and devices for their administration
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
EP1036562A1 (en) * 1997-12-03 2000-09-20 Fujisawa Pharmaceutical Co., Ltd. Soft-pellet drug and process for the preparation thereof
US6458338B1 (en) 1998-09-22 2002-10-01 Aeropharm Technology Incorporated Amino acid stabilized medicinal aerosol formulations
AU7685200A (en) 1999-10-12 2001-04-23 Kaken Pharmaceutical Co., Ltd. Powdery inhalational preparations and process for producing the same
GB9928311D0 (en) * 1999-11-30 2000-01-26 Novartis Ag Organic compounds
GB0010709D0 (en) * 2000-05-03 2000-06-28 Vectura Ltd Powders for use a in dry powder inhaler
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
MXPA04005865A (es) 2001-12-19 2004-09-13 Nektar Therapeutics Suministro de aminoglucosidos a los pulmones.
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
JP2006087815A (ja) * 2004-09-27 2006-04-06 Canon Inc 噴霧方法および該方法に基づく噴霧装置
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
US20090123390A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Compositions for the treatment of gastrointestinal inflammation
ES2729925T3 (es) 2007-11-13 2019-11-07 Meritage Pharma Inc Composiciones de corticosteroides
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
EP2440210A4 (en) * 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
JP2020510002A (ja) * 2017-03-07 2020-04-02 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム 吸入可能なニコチン製剤、およびその作製および使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201685B (en) * 1987-04-23 1990-12-28 Chinoin Gyogyszer Es Vegyeszet For producing pharmaceutical compositions for inhalation and compositions for scenting air containing volatile active component in cyclodextrine inclusion, and air-scenting composition
GB8820398D0 (en) * 1988-08-27 1988-09-28 Fisons Plc Pharmaceutical formulation
GB9001635D0 (en) * 1990-01-24 1990-03-21 Ganderton David Aerosol carriers

Also Published As

Publication number Publication date
GR3022527T3 (en) 1997-05-31
CA2131285C (en) 2004-06-29
NO307203B1 (no) 2000-02-28
JPH07504432A (ja) 1995-05-18
EP0630230A1 (en) 1994-12-28
DK0630230T3 (da) 1997-06-02
ATE145819T1 (de) 1996-12-15
FI110162B (sv) 2002-12-13
NO943241D0 (no) 1994-09-01
JP2736168B2 (ja) 1998-04-02
US5607662A (en) 1997-03-04
EP0630230B1 (en) 1996-12-04
DE69306379T2 (de) 1997-06-12
CA2131285A1 (en) 1993-09-16
WO1993017663A1 (en) 1993-09-16
ES2099428T3 (es) 1997-05-16
FI944123A (sv) 1994-09-08
NO943241L (no) 1994-09-01
DE69306379D1 (de) 1997-01-16

Similar Documents

Publication Publication Date Title
FI944123A (sv) Farmaceutiska inhalationssammansättningar
DE69518334D1 (de) Pharmazeutische aerosol welche mindestens ein zucker enthält
DE69532031D1 (de) Schilddrüsenhormone enthaltende mittel
RU98111594A (ru) Фармацевтические композиции, включающие флурбипрофен
ES2111304T3 (es) Composicion de administracion por via nasal de un medicamento que contiene nicotina.
AU1358695A (en) Nasal administration
CA2240717A1 (en) Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
TR200100569T2 (tr) Mukozaya yapışan (muko-adhesif) oral sıvı bileşimler
HUP9802828A2 (hu) Belélegezhető vivőanyag szabályozott hatóanyag-leadású gyógyszerkészítményekhez
DE69132688D1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
TR200100628T2 (tr) Mukozaya yapışan (muko-adhesif) oral sıvı bileşimler.
DE69325643D1 (de) Zusammensetzung zur raucherentwöhnung
JPH072654A (ja) 吸入によるタウリン投与装置
ATE213626T1 (de) Feste, therapeutische oder hygienische, mucoadhäsive zusammensetzung zur verabreichung durch auftragen auf der mund-schleimhaut oder der nasen-schleimhaut
KR920703041A (ko) 통증을 수반하는 염증성 또는 알레르기성 질환치료에 사용되는 성분물과 그 방법
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
MY124465A (en) Reduction of infarct volume using citicoline
IL112288A (en) Use of riluzole in the manufacture of a medicament for the treatment of mitochondrial diseases
ATE91890T1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
EP0397211A3 (en) Percutaneous administration of 3'-azide-3'-deoxythymidine
RU94016196A (ru) Способ лечения больных брюшным тифом
KR910005856A (ko) 호흡기 질환 치료용 제약 조성물
KR890014115A (ko) 4-(3-포스포노-2-프로페닐)-2-피페라진카르복실산의 신규한 용도